Skip to main content
Long-term SGLT2 inhibitor use may lower new-onset stroke risk in T2D
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Long-term SGLT2 inhibitor use may lower new-onset stroke risk in T2D
User login
Username
Password
Reset your password
Concept
Lead
score
Cerebrovascular Accident
1
1
Type 2 Diabetes Mellitus
0
1
SGLT2 Inhibitor
0
0.86
Stroke Risk
0
0.65
Statins
0
0.25
Lipids Management
0
0.2
Grant
0
0.12
Specialty
Lead
score
Diabetes & Endocrinology
1
1
Cardiology
0
0.71
Neurology & Neurosurgery
0
0.71
Family Medicine/Primary Care
0
0.7
Public Health & Prevention
0
0.63
Internal Medicine
0
0.57
Edit Tags